For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Solid Tumors
- Haematological Malignancies
Companies Covered:
- Adaptate Biotherapeutics Ltd
- Adicet Bio
- American Gene Technologies International Inc.
- CytoMed Therapeutics Pte Ltd
- Editas Medicine
- GammaDelta Therapeutics Limited
- ImCheck Therapeutics SAS
- Immatics Biotechnologies GmbH
- Lava Therapeutics B.V.
- Leucid Bio Ltd
- PhosphoGam Inc.
- Sandhill Therapeutics
- Shattuck Labs
- Gadeta BV
- TC BioPharm Limited
- In8bio
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Adaptate Biotherapeutics Ltd
- Adicet Bio
- American Gene Technologies International Inc.
- CytoMed Therapeutics Pte Ltd
- Editas Medicine
- GammaDelta Therapeutics Limited
- ImCheck Therapeutics SAS
- Immatics Biotechnologies GmbH
- Lava Therapeutics B.V.
- Leucid Bio Ltd
- PhosphoGam Inc.
- Sandhill Therapeutics
- Shattuck Labs
- Gadeta BV
- TC BioPharm Limited
- In8bio

